| For: | Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Compagnon P, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouillères O, Cherqui D, Duvoux C. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients. World J Gastroenterol 2006; 12(45): 7319-7325 [PMID: 17143948 DOI: 10.3748/wjg.v12.i45.7319] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i45/7319.htm |
| Number | Citing Articles |
| 1 |
T. Decaens, M. Hurtova, C. Duvoux. Transplantation hépatique pour carcinome hépatocellulaire. Gastroentérologie Clinique et Biologique 2009; 33(1) doi: 10.1016/j.gcb.2008.11.005
|
| 2 |
Wu Junyi, Sun Hongcheng, Han Zhongbo, Peng Zhihai. A single center experience: post-transplantation adjuvant chemotherapy impacts the prognosis of hepatocellular carcinoma patients. Chinese Medical Journal 2014; 127(3) doi: 10.3760/cma.j.issn.0366-6999.20120126
|
| 3 |
Utz Settmacher, Falk Rauchfuß, Michael Bauer, Astrid Bauschke, Susanne Beckebaum, Alfred Königsrainer, Christina Malessa, Silvio Nadalin, Silke Rummler, Andreas Kortgen, Lara Genedy. Organtransplantation mit Lebendspende. 2023; doi: 10.1007/978-3-662-65736-2_8
|
| 4 |
Yuan-Yuan Liu, Chang-Ping Li, Ming-Sheng Huai, Xiao-Meng Fu, Zhuang Cui, Lin-Lin Fan, Shu Zhang, Yuan Liu, Jun Ma, Guang Li, Zhong-Yang Shen, Song Guo Zheng. Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression. PLOS ONE 2015; 10(3) doi: 10.1371/journal.pone.0120939
|
| 5 |
Safak Gül-Klein, Anika Kästner, Philipp Konstantin Haber, Felix Krenzien, Simon Wabitsch, Alexander Krannich, Andreas Andreou, Dennis Eurich, Frank Tacke, David Horst, Johann Pratschke, Moritz Schmelzle. Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S292010
|
| 6 |
Maya Horowitz, Elad Neeman, Eran Sharon, Shamgar Ben-Eliyahu. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nature Reviews Clinical Oncology 2015; 12(4) doi: 10.1038/nrclinonc.2014.224
|
| 7 |
Jan Lerut, Quirino Lai. Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation 2023; 107(7) doi: 10.1097/TP.0000000000004488
|
| 8 |
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(02) doi: 10.1055/a-2189-8567
|
| 9 |
Christophe Duvoux, Christian Toso. mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?. Transplantation Reviews 2015; 29(3) doi: 10.1016/j.trre.2015.02.003
|
| 10 |
A. Bauschke, A. Altendorf-Hofmann, H. Kissler, A. Koch, C. Malessa, U. Settmacher. Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation. Journal of Cancer Research and Clinical Oncology 2017; 143(12) doi: 10.1007/s00432-017-2507-2
|
| 11 |
Claire Durkin, Douglas E. Schaubel, Yuwen Xu, Nadim Mahmud, David E. Kaplan, Peter L. Abt, Therese Bittermann. Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation 2023; 107(7) doi: 10.1097/TP.0000000000004487
|
| 12 |
Aglaia Domouchtsidou, Ferdinand Beckmann, Beate Marenbach, Stefan P. Mueller, Jan Best, Ken Herrmann, Peter A. Horn, Vahé Barsegian, Monika Lindemann. In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival. Cancers 2023; 15(16) doi: 10.3390/cancers15164055
|
| 13 |
Andreas A. Schnitzbauer, Hans J. Schlitt, Edward K. Geissler. Influence of Immunosuppressive Drugs on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Gap Between Basic Science and Clinical Evidence. Transplantation 2011; 91(11) doi: 10.1097/TP.0b013e318215e72b
|
| 14 |
Kan Chen, Kwan Man, Herold J. Metselaar, Harry L. A. Janssen, Maikel P. Peppelenbosch, Qiuwei Pan. Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantation. Liver Transplantation 2014; 20(3) doi: 10.1002/lt.23806
|
| 15 |
Maryam Moini, Michael L Schilsky, Eric M Tichy. Review on immunosuppression in liver transplantation. World Journal of Hepatology 2015; 7(10): 1355-1368 doi: 10.4254/wjh.v7.i10.1355
|
| 16 |
Tsuyoshi Kadosawa, Ai Watabe. The effects of surgery-induced immunosuppression and angiogenesis on tumour growth. The Veterinary Journal 2015; 205(2) doi: 10.1016/j.tvjl.2015.04.009
|
| 17 |
Fusheng Liu, Haitao Wang, Weijie Ma, Jinghua Li, Yingyi Liu, Shengli Tang, Kun Li, Ping Jiang, Zhiyong Yang, Yueming He, Zhisu Liu, Zhonglin Zhang, Yufeng Yuan. Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation- Versus Conventional-Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Matched, Retrospective, Cohort Study. Annals of Surgical Oncology 2023; 30(4) doi: 10.1245/s10434-022-13027-5
|
| 18 |
Carolina Palma, Francisco Vara-Luíz, Ivo Mendes, Bruno Correia, Filipe Nogueira, Cristina Fonseca. Paraneoplastic Pemphigus and Liver Biopsy Needle Track Dissemination in Hepatocellular Carcinoma: A Case Report. GE - Portuguese Journal of Gastroenterology 2026; doi: 10.1159/000550555
|
| 19 |
Stéphanie Lacotte, Graziano Oldani, Florence Slits, Lorenzo A. Orci, Laura Rubbia-Brandt, Philippe Morel, Gilles Mentha, Christian Toso, Jacques Zimmer. Alloimmune Activation Promotes Anti-Cancer Cytotoxicity after Rat Liver Transplantation. PLoS ONE 2014; 9(3) doi: 10.1371/journal.pone.0091515
|
| 20 |
Andrea Notarpaolo, Richard Layese, Paolo Magistri, Maria Gambato, Michele Colledan, Giulia Magini, Lucia Miglioresi, Alessandro Vitale, Giovanni Vennarecci, Cecilia D Ambrosio, Patrizia Burra, Fabrizio Di Benedetto, Stefano Fagiuoli, Marco Colasanti, Giuseppe Maria Ettorre, Arnoldo Andreoli, Umberto Cillo, Alexis Laurent, Sandrine Katsahian, Etienne Audureau, Françoise Roudot-Thoraval, Christophe Duvoux. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. Journal of Hepatology 2017; 66(3) doi: 10.1016/j.jhep.2016.10.038
|
| 21 |
Sun Kyung Jang, Gi Hong Choi, Junjeong Choi, Xiaoyuan Quan, Jeong Won Jang, Bo Hyun Kim, Guhung Jung, Young Min Park. Co-expression patterns of Notch1, Snail, and p53 in grade III hepatocellular carcinoma with postoperative recurrence: a preliminary study. The Korean Journal of Hepatology 2012; 18(1) doi: 10.3350/kjhep.2012.18.1.63
|
| 22 |
Christian Toso, Sonia Cader, Ariane Mentha‐Dugerdil, Glenda Meeberg, Pietro Majno, Isabelle Morard, Emiliano Giostra, Thierry Berney, Philippe Morel, Gilles Mentha, Norman M. Kneteman. Factors predicting survival after post‐transplant hepatocellular carcinoma recurrence. Journal of Hepato-Biliary-Pancreatic Sciences 2013; 20(3) doi: 10.1007/s00534-012-0528-4
|
| 23 |
François Durand, Claire Francoz. Evidence‐based Gastroenterology and Hepatology 4e. 2019; doi: 10.1002/9781119211419.ch48
|
| 24 |
K. Dudek, O. Kornasiewicz, P. Remiszewski, K. Kobryń, B. Ziarkiewicz-Wróblewska, B. Górnicka, K. Zieniewicz, M. Krawczyk. Impact of Tumor Characteristic on the Outcome of Liver Transplantation in Patients With Hepatocellular Carcinoma. Transplantation Proceedings 2009; 41(8) doi: 10.1016/j.transproceed.2009.08.016
|
| 25 |
François Durand, Claire Francoz, Jacques Belghiti. Malignant Liver Tumors. 2010; doi: 10.1002/9781444317053.ch23
|
| 26 |
Christophe Duvoux, Tetsuya Kiuchi, Bernhard Pestalozzi, Ronald Busuttil, Rebecca Miksad. What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?. Liver Transplantation 2011; 17(Supplement 2) doi: 10.1002/lt.22367
|
| 27 |
Monika Hurtova, Thomas Decaens, Alexis Laurent, Daniel Cherqui, Christophe Duvoux. Transplantation hépatique pour carcinome hépatocellulaire et chez les malades avec antécédents de cancer. La Presse Médicale 2009; 38(9) doi: 10.1016/j.lpm.2009.05.001
|
| 28 |
Michael A. Zimmerman, Mara A. Kelly, Jeffrey Campsen, M. Susan Mandell, Michael Wachs, Tom Bak, Afshin Skibba, Brian Lancaster, Igal Kam. The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation. Clinical Transplantation 2010; 24(4) doi: 10.1111/j.1399-0012.2009.01179.x
|
| 29 |
Elad Neeman, Shamgar Ben-Eliyahu. Surgery and stress promote cancer metastasis: New outlooks on perioperative mediating mechanisms and immune involvement. Brain, Behavior, and Immunity 2013; 30 doi: 10.1016/j.bbi.2012.03.006
|
| 30 |
Emad H. Asham, Ahmed Kaseb, R. Mark Ghobrial. Management of Hepatocellular Carcinoma. Surgical Clinics of North America 2013; 93(6) doi: 10.1016/j.suc.2013.08.008
|
| 31 |
Julie K. Heimbach. Liver Transplantation for Hepatocellular Carcinoma. The Cancer Journal 2008; 14(2) doi: 10.1097/PPO.0b013e31816a0f6f
|
| 32 |
T. Decaens, C. Duvoux. Carcinome hépatocellulaire et transplantation hépatique : rôle futur des inhibiteurs de la mTOR. Gastroentérologie Clinique et Biologique 2009; 33 doi: 10.1016/S0399-8320(09)73163-X
|
| 33 |
EASL Clinical Practice Guidelines: Liver transplantation. Journal of Hepatology 2016; 64(2) doi: 10.1016/j.jhep.2015.10.006
|
| 34 |
Poh Seng Tan, Mark D. Muthiah, Tsingyi Koh, Yee Leong Teoh, Albert Chan, Alfred Kow, Qishi Zheng, Choon Hyuck David Kwon, Guan Huei Lee, Cosmas Rinaldi A. Lesmana, Vanessa de Villa, James Fung, Kieron Lim. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation. Transplantation 2019; 103(3) doi: 10.1097/TP.0000000000002532
|
| 35 |
Thomas Berg, Niklas F. Aehling, Tony Bruns, Martin-Walter Welker, Tobias Weismüller, Jonel Trebicka, Frank Tacke, Pavel Strnad, Martina Sterneck, Utz Settmacher, Daniel Seehofer, Eckart Schott, Andreas Anton Schnitzbauer, Hartmut H. Schmidt, Hans J. Schlitt, Johann Pratschke, Andreas Pascher, Ulf Neumann, Steffen Manekeller, Frank Lammert, Ingo Klein, Gabriele Kirchner, Markus Guba, Matthias Glanemann, Cornelius Engelmann, Ali E. Canbay, Felix Braun, Christoph P. Berg, Wolf O. Bechstein, Thomas Becker, Christian Trautwein. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV). Zeitschrift für Gastroenterologie 2024; 62(09) doi: 10.1055/a-2255-7246
|
| 36 |
Jérôme Dumortier, Sebastien Dharancy, Yvon Calmus, Christophe Duvoux, François Durand, Ephrem Salamé, Faouzi Saliba. Use of everolimus in liver transplantation: The French experience. Transplantation Reviews 2016; 30(3) doi: 10.1016/j.trre.2015.12.003
|
| 37 |
A. R. Hakeem, R. S. Young, G. Marangoni, J. P. A. Lodge, K. R. Prasad. Systematic review: the prognostic role of alpha‐fetoprotein following liver transplantation for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2012; 35(9) doi: 10.1111/j.1365-2036.2012.05060.x
|
| 38 |
Letizia Todeschini, Luca Cristin, Alessandro Martinino, Amelia Mattia, Salvatore Agnes, Francesco Giovinazzo. The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma. Current Oncology 2023; 30(6) doi: 10.3390/curroncol30060421
|
| 39 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(01) doi: 10.1055/a-2189-6353
|
| 40 |
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Katrin Borucki, Thomas Brunner, Reiner Caspari, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Jamila Gebert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Julia Ott, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Kristina Ringe, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Kerstin Schütte, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Jörg Trojan, Ingo van Thiel, Martin Utzig, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Gregor Wenzel, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion. Zeitschrift für Gastroenterologie 2025; 63(02) doi: 10.1055/a-2460-6347
|
| 41 |
Nicholas Onaca, Marvin J. Stone, James M. Fulmer, Göran B.G. Klintmalm. Transplantation of the Liver. 2015; doi: 10.1016/B978-1-4557-0268-8.00016-6
|
| 42 |
Vincent Donckier, Ligia Craciun, Patrick Miqueu, Roberto Ivan Troisi, Valerio Lucidi, Xavier Rogiers, Nathalie Boon, Delphine Degré, Alexis Buggenhout, Christophe Moreno, Thierry Gustot, Maurizio Sainz-Barriga, Nadine Bourgeois, Isabelle Colle, Hans Van Vlierberghe, Mohammed Amrani, Myriam Remmelink, Arnaud Lemmers, Dave L. Roelen, Frans H. Claas, Petra Reinke, Birgit Sawitzki, Hans Dieter Volk, Alain Le Moine, Bernard de Hemptinne, Michel Goldman. Expansion of Memory-Type CD8+ T Cells Correlates With the Failure of Early Immunosuppression Withdrawal After Cadaver Liver Transplantation Using High-Dose ATG Induction and Rapamycin. Transplantation 2013; 96(3) doi: 10.1097/TP.0b013e3182985414
|
| 43 |
Christian Toso, Glenda Meeberg, Roberto Hernandez‐Alejandro, Jean‐François Dufour, Paul Marotta, Pietro Majno, Norman M. Kneteman. Total tumor volume and alpha‐fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation. Hepatology 2015; 62(1) doi: 10.1002/hep.27787
|
| 44 |
C.P. Strassburg, M.J. Bahr, T. Becker, J. Klempnauer, M.P. Manns. Fortschritte in der Immunsuppression. Der Chirurg 2008; 79(2) doi: 10.1007/s00104-007-1456-8
|
| 45 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Katrin Borucki, Thomas Brunner, Reiner Caspari, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Jamila Gebert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Julia Ott, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Kristina Ringe, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Kerstin Schütte, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Jörg Trojan, Ingo van Thiel, Martin Utzig, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Gregor Wenzel, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion. Zeitschrift für Gastroenterologie 2025; 63(03) doi: 10.1055/a-2460-6298
|
| 46 |
Elad Neeman, Oded Zmora, Shamgar Ben-Eliyahu. A New Approach to Reducing Postsurgical Cancer Recurrence: Perioperative Targeting of Catecholamines and Prostaglandins. Clinical Cancer Research 2012; 18(18) doi: 10.1158/1078-0432.CCR-12-1087
|
| 47 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion. Zeitschrift für Gastroenterologie 2023; 61(04) doi: 10.1055/a-2026-1240
|
| 48 |
Daniel Hoffman, Neil Mehta. Recurrence of hepatocellular carcinoma following liver transplantation. Expert Review of Gastroenterology & Hepatology 2021; 15(1) doi: 10.1080/17474124.2021.1823213
|
| 49 |
Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation. Clinical and Molecular Hepatology 2014; 20(2) doi: 10.3350/cmh.2014.20.2.192
|
| 50 |
Olga Ciccarelli, Quirino Lai, Pierre Goffette, Patrice Finet, Chantal De Reyck, Francine Roggen, Christine Sempoux, Erik Doffagne, Raymond Reding, Jan Lerut. Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria. Transplant International 2012; 25(8) doi: 10.1111/j.1432-2277.2012.01512.x
|
| 51 |
Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo. Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma. Clinical and Molecular Hepatology 2021; 27(4) doi: 10.3350/cmh.2021.0038
|
| 52 |
Christophe Duvoux, Françoise Roudot–Thoraval, Thomas Decaens, Fabienne Pessione, Hanaa Badran, Tullio Piardi, Claire Francoz, Philippe Compagnon, Claire Vanlemmens, Jérome Dumortier, Sébastien Dharancy, Jean Gugenheim, Pierre–Henri Bernard, René Adam, Sylvie Radenne, Fabrice Muscari, Filomena Conti, Jean Hardwigsen, Georges–Philippe Pageaux, Olivier Chazouillères, Ephrem Salame, Marie–Noelle Hilleret, Pascal Lebray, Armand Abergel, Marilyne Debette–Gratien, Michael D. Kluger, Ariane Mallat, Daniel Azoulay, Daniel Cherqui. Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria. Gastroenterology 2012; 143(4) doi: 10.1053/j.gastro.2012.05.052
|
| 53 |
Wei Geng, Chung-Mau Lo, Kevin T.P. Ng, Chang-Chun Ling, Xiang Qi, Chang-Xian Li, Yuan Zhai, Xiao-Bing Liu, Yuen-Yuen Ma, Kwan Man. Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway. Oncotarget 2015; 6(29) doi: 10.18632/oncotarget.4832
|
| 54 |
Jan Lerut, Olivier Julliard, Olga Ciccarelli, Valerie Lannoy, Pierre Gofette. Multidisciplinary Treatment of Hepatocellular Carcinoma. Recent Results in Cancer Research 2013; 190 doi: 10.1007/978-3-642-16037-0_9
|
| 55 |
Sara M. Lewin, Neil Mehta, R. Kate Kelley, John P. Roberts, Francis Y. Yao, Danielle Brandman. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transplantation 2017; 23(8) doi: 10.1002/lt.24764
|
| 56 |
Steven C. Cunningham, Susan Tsai, Hugo P. Marques, Paulo Mira, Andrew Cameron, Eduardo Barroso, Benjamin Philosophe, Timothy M. Pawlik. Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis. Annals of Surgical Oncology 2009; 16(7) doi: 10.1245/s10434-009-0364-1
|
| 57 |
A. Hollebecque, T. Decaens, E. Boleslawski, P. Mathurin, C. Duvoux, F.-R. Pruvot, S. Dharancy. Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. Gastroentérologie Clinique et Biologique 2009; 33(5) doi: 10.1016/j.gcb.2009.02.036
|
| 58 |
Lionel Rostaing, Faouzi Saliba, Yvon Calmus, Sébastien Dharancy, Olivier Boillot. Review article: Use of induction therapy in liver transplantation. Transplantation Reviews 2012; 26(4) doi: 10.1016/j.trre.2012.06.002
|
| 59 |
C. Toso, G. Mentha, P. Majno. Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence. American Journal of Transplantation 2011; 11(10) doi: 10.1111/j.1600-6143.2011.03689.x
|
| 60 |
Voesch Sabrina, Bitzer Michael, Albert Jörg, Bartenstein Peter, Bechstein Wolf, Blödt Susanne, Brunner Thomas, Dombrowski Frank, Evert Matthias, Follmann Markus, La Fougère Christian, Freudenberger Paul, Geier Andreas, Gkika Eleni, Götz Martin, Hammes Elke, Helmberger Thomas, Hoffmann Ralf-Thorsten, Hofmann Wolf-Peter, Huppert Peter, Kautz Achim, Knötgen Gabi, Körber Jürgen, Krug David, Lammert Frank, Lang Hauke, Langer Thomas, Lenz Philipp, Mahnken Andreas, Meining Alexander, Micke Oliver, Nadalin Silvio, Nguyen Huu Phuc, Ockenga Johann, Oldhafer Karl-Jürgen, Paprottka Philipp, Paradies Kerstin, Pereira Philippe, Persigehl Thorsten, Plauth Mathias, Plentz Ruben, Pohl Jürgen, Riemer Jutta, Reimer Peter, Ringwald Johanna, Ritterbusch Ulrike, Roeb Elke, Schellhaas Barbara, Schirmacher Peter, Schmid Irene, Schuler Andreas, von Schweinitz Dietrich, Seehofer Daniel, Sinn Marianne, Stein Alexander, Stengel Andreas, Steubesand Nadine, Stoll Christian, Tannapfel Andrea, Taubert Anne, Trojan Jörg, van Thiel Ingo, Tholen Reina, Vogel Arndt, Vogl Thomas, Vorwerk Hilke, Wacker Frank, Waidmann Oliver, Wedemeyer Heiner, Wege Henning, Wildner Dane, Wittekind Christian, Wörns Marcus-Alexander, Galle Peter, Malek Nisar. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms. Zeitschrift für Gastroenterologie 2022; 60(01) doi: 10.1055/a-1589-7568
|